← Leaderboards
Harry William Schroeder
University Of Alabama At Birmingham
$20,383,747
Attributed
$20,383,747
Total exposure
18
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$20,383,747 · 18
By mechanism
T32$7,408,595 · 1
R01$6,289,422 · 4
R21$3,242,708 · 8
U01$2,922,449 · 1
R56$366,250 · 1
M01$154,323 · 3
Top collaborators
No co-investigators on record.
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Max D Cooper$23,641,392
- Zhixin Zhang$4,197,162
- John Franklin Kearney$21,145,276
- Richard A Kaslow$6,549,974
- Jianming Tang$7,968,768
Others in their field
Top investigators on “Immunoglobulins”
- Dennis R. Burton · Scripps Research Institute$274,309,511
- Carol Nesel · Westat$147,274,423
- Barbara Driver · Westat, Inc.$95,592,456
- Beth Baseler · Leidos Biomedical Research, Inc.$87,027,148
- James E Crowe · Vanderbilt University Medical Center$56,254,983
- Jeffrey Victor Ravetch · Rockefeller University$39,074,258
Research focus
ImmunoglobulinsB-LymphocytesAntibodiesInfectionGene TargetingImmune System DiseasesAntibody FormationImmuneImmunologyReportingAllelesAntigen BindingTyrosineBinding SitesAntigensAmino AcidsImmune ResponseProductionPatternAutoimmunityChargePreventB LymphocyteImmunologist
Grant awards (65)
Divergence of V-region sequences from the human proteome as a factor in autoimmune diseases and the immunogenicity of therapeutic antibodies.$216,068
R21 · FY2025 · AI · contact PI
Divergence of V-region sequences from the human proteome as a factor in autoimmune diseases and the immunogenicity of therapeutic antibodies.$185,625
R21 · FY2024 · AI · contact PI
Role of the immunoglobulin DQ52 DH gene segment in fetal immunosuppression$185,625
R21 · FY2023 · AI · contact PI
Immunologic Diseases and Basic Immunology$436,674
T32 · FY2022 · AI · contact PI
Role of the immunoglobulin DQ52 DH gene segment in fetal immunosuppression$222,750
R21 · FY2022 · AI · contact PI
Immunologic Diseases and Basic Immunology$501,756
T32 · FY2021 · AI · contact PI
Immunologic Diseases and Basic Immunology$467,180
T32 · FY2020 · AI · contact PI
Immunologic Diseases and Basic Immunology$496,866
T32 · FY2019 · AI · contact PI
Role of VpreB in immunoglobulin antigen binding site selection$185,625
R21 · FY2019 · AI · contact PI
Immunologic Diseases and Basic Immunology$492,876
T32 · FY2018 · AI · contact PI
Role of VpreB in immunoglobulin antigen binding site selection$222,750
R21 · FY2018 · AI · contact PI
Immunologic Diseases and Basic Immunology$433,861
T32 · FY2017 · AI · contact PI
Immunologic Diseases and Basic Immunology$363,474
T32 · FY2016 · AI · contact PI
The pre-BCR CDR-H3 sensing site and H chain selection$183,750
R21 · FY2016 · AI · contact PI
Immunologic Diseases and Basic Immunology$464,018
T32 · FY2015 · AI · contact PI
The pre-BCR CDR-H3 sensing site and H chain selection$220,500
R21 · FY2015 · AI · contact PI
HLA Region and KIR Genomics in Common Variable Immune Deficiency$534,850
U01 · FY2014 · AI · contact PI
Immunologic Diseases and Basic Immunology$322,146
T32 · FY2014 · AI · contact PI
HLA Region and KIR Genomics in Common Variable Immune Deficiency$486,584
U01 · FY2013 · AI · contact PI
Immunologic Diseases and Basic Immunology$448,680
T32 · FY2013 · AI · contact PI
Role of IG CDR-H3 in Responses to HIV Vaccines$343,366
R01 · FY2013 · AI · contact PI
HLA Region and KIR Genomics in Common Variable Immune Deficiency$760,281
U01 · FY2012 · AI · contact PI
The Role of Immunoglobulin CDRH3 in Autoimmune Disease$366,250
R56 · FY2012 · AI · contact PI
Role of IG CDR-H3 in Responses to HIV Vaccines$365,205
R01 · FY2012 · AI · contact PI
Immunologic Diseases and Basic Immunology$590,618
T32 · FY2011 · AI · contact PI
HLA Region and KIR Genomics in Common Variable Immune Deficiency$570,645
U01 · FY2011 · AI · contact PI
Role of IG CDR-H3 in Responses to HIV Vaccines$365,129
R01 · FY2011 · AI · contact PI
Role of immunoglobulin CDR-H3 in heterosubtypic immunity to influenza virus$217,553
R21 · FY2011 · AI · contact PI
HLA Region and KIR Genomics in Common Variable Immune Deficiency$570,089
U01 · FY2010 · AI · contact PI
Immunologic Diseases and Basic Immunology$535,775
T32 · FY2010 · AI · contact PI
Role of IG CDR-H3 in Responses to HIV Vaccines$380,367
R01 · FY2010 · AI · contact PI
The role of Immunoglobulin CDRH3 in Autoimmune Disease$308,723
R01 · FY2010 · AI · contact PI
Role of immunoglobulin CDR-H3 in heterosubtypic immunity to influenza virus$183,125
R21 · FY2010 · AI · contact PI
Immunologic Diseases and Basic Immunology$626,574
T32 · FY2009 · AI · contact PI
The role of Immunoglobulin CDRH3 in Autoimmune Disease$435,069
R01 · FY2009 · AI · contact PI
Immunoglobulin CDR-H3 and neutralizing antibodies to HIV$278,336
R21 · FY2009 · AI · contact PI
HLA*B Associated Genes and Memory B cells in patients with CVID$210,750
R21 · FY2009 · AI · contact PI
HLA*B Associated Genes and Memory B cells in patients with CVID$183,868
R21 · FY2009 · AI · contact PI
Immunologic Diseases and Basic Immunology$617,930
T32 · FY2008 · AI · contact PI
The role of Immunoglobulin CDRH3 in Autoimmune Disease$311,841
R01 · FY2008 · AI · contact PI
Immunoglobulin CDR-H3 and neutralizing antibodies to HIV$231,500
R21 · FY2008 · AI · contact PI
HLA*B Associated Genes and Memory B cells in patients with CVID$176,750
R21 · FY2008 · AI · contact PI
Immunologic Diseases and Basic Immunology$610,167
T32 · FY2007 · AI · contact PI
The role of Immunoglobulin CDRH3 in Autoimmune Disease$317,881
R01 · FY2007 · AI · contact PI
The role of Immunoglobulin CDRH3 in Autoimmune Disease$158,450
R01 · FY2007 · AI · contact PI
BIOLOGICAL DEFINITION OF HOST DEFENSE DEFECTS IN MAN$40,688
M01 · FY2007 · RR · contact PI
The role of Immunoglobulin CDRH3 in Autoimmune Disease$352,375
R01 · FY2006 · AI · contact PI
BIOLOGICAL DEFINITION OF HOST DEFENSE DEFECTS IN MAN$34,545
M01 · FY2006 · RR · contact PI
DEVELOPMENT OF THE ANTIBODY REPERTOIRE$287,000
R01 · FY2005 · AI
BIOLOGICAL DEFINITION OF HOST DEFENSE DEFECTS IN MAN$36,474
M01 · FY2005 · RR
DEVELOPMENT OF THE ANTIBODY REPERTOIRE$287,000
R01 · FY2004 · AI
IMMUNOGLOBULIN HCDR3 IN AUTOIMMUNE DISEASE$251,125
R01 · FY2004 · AI
BIOLOGICAL DEFINITION OF HOST DEFENSE DEFECTS IN MAN$32,100
M01 · FY2004 · RR
Rapid Infusion Trial in Primary Immune Deficient Patient$10,516
M01 · FY2004 · RR
DEVELOPMENT OF THE ANTIBODY REPERTOIRE$287,000
R01 · FY2003 · AI
IMMUNOGLOBULIN HCDR3 IN AUTOIMMUNE DISEASE$251,125
R01 · FY2003 · AI
TCRb CDR3 and Susceptibility to Autoimmune Disease$66,383
R21 · FY2003 · AR
DEVELOPMENT OF THE ANTIBODY REPERTOIRE$287,000
R01 · FY2002 · AI
IMMUNOGLOBULIN HCDR3 IN AUTOIMMUNE DISEASE$213,456
R01 · FY2002 · AI
TCRb CDR3 and Susceptibility to Autoimmune Disease$71,750
R21 · FY2002 · AR
DEVELOPMENT OF THE ANTIBODY REPERTOIRE$312,000
R01 · FY2001 · AI
IMMUNOGLOBULIN HCDR3 IN AUTOIMMUNE DISEASE$251,125
R01 · FY2001 · AI
IMMUNOGLOBULIN HCDR3 IN AUTOIMMUNE DISEASE$276,125
R01 · FY2000 · AI
ONTOGENY OF THE PERINATAL ANTIBODY REPERTOIRE$248,060
R01 · FY2000 · HD
COMPARING IGIV CHROMATOGRAPHY IN PRIMARY IMMUNE DEFICIEN$0
M01 · FY2000 · RR